Direct Compression vs. Granulation: OEM Tablet Route Selection

Start with the problem the route must solve

A brand planning a botanical tablet may receive two proposals: compress the blend directly or prepare granules first. Request the reason for each proposal before comparing prices. The useful question is whether the chosen route can deliver the agreed formula, tablet geometry, and quality criteria repeatedly with the specified materials.

Prepare a decision sheet listing the complete blend, preferred serving count, ingredient restrictions, and packaging plan. Add known concerns such as difficult feeding, tablet breakage, or moisture exposure during preparation. Keep commercial preferences visible, but allow the development team to identify where a preferred route needs additional evidence.

Separate route names from performance evidence

Direct compression omits a separate granulation operation; granulation introduces a particle preparation step. Neither description proves that the resulting tablet is suitable. Pharmaceutical experiments have compared routes for particular troublesome materials. Their results illustrate a development approach rather than a rule that one route will outperform another in every supplement.

Ask for a side by side trial using identified ingredient grades and a consistent tablet target. Review the trial results together instead of accepting a single favorable measurement. An appealing surface is useful, but it should sit beside the agreed checks for handling, ingredient content, and other relevant finished product characteristics.

Document what each preparation step changes

For a proposed granulation route, request a description of the materials and processing stages being added. Identify any new binder, liquid, drying operation, or intermediate storage. Ask which existing formula restrictions remain feasible and which require a decision. A manufacturing explanation should make these changes understandable to the purchasing team.

For direct compression, discuss how the blend will be transferred and supplied to the press during the intended run. A bench blend that makes several attractive tablets is a useful starting point. The commercial decision also needs an assessment of sustained operation and the consequences of ordinary interruptions or material replenishment.

Compare commercial implications on the same basis

Prepare one quote comparison with the same pack count, testing scope, approved materials, and release responsibilities. Ask each supplier to identify development work separately from recurring production. If tooling or an added preparation stage is needed, clarify ownership, repeat use, and how the associated work affects the project schedule.

Use an explicit decision gate after the trial. For example, accept the proposed route only when the team resolves the previously identified feeding and handling concerns. This keeps a purchasing decision from silently becoming a technical approval. Record unresolved items and the person responsible for reviewing the next set of samples.

Preserve the route decision for repeat orders

The approved route should be linked to the blend revision, ingredient grades, trial record, and finished tablet specification. Ask how a new material supplier or a change in preparation equipment would be evaluated. A route name on an invoice is too broad to explain whether the original evidence still represents a later batch.

Build a short handoff package that explains why the route was selected and which observations supported it. Include any limitations, outstanding stability work, and allowed component alternatives. Future buyers can then distinguish an established repeat order from a development change, even when the marketing name of the product remains the same.

Common questions